These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9172005)

  • 21. Bioavailability and pharmacokinetics of furosemide marketed in Thailand.
    Kaojarern S; Poobrasert O; Utiswannakul A; Kositchaiwat U
    J Med Assoc Thai; 1990 Apr; 73(4):191-7. PubMed ID: 2394955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults.
    Park K; Kim YS; Kwon KI; Park MS; Lee YJ; Kim KH
    Clin Ther; 2007 Jan; 29(1):154-62. PubMed ID: 17379055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability and selected pharmacokinetic parameters of clindamycin hydrochloride after administration of a new 600 mg tablet formulation.
    Mazur D; Schug BS; Evers G; Larsimont V; Fieger-Büschges H; Gimbel W; Keilbach-Bermann A; Blume HH
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):386-92. PubMed ID: 10475141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative bioavailability of two formulations of azithromycin.
    Gulati R; Tripathi CD; Chandra D
    J Assoc Physicians India; 2000 Jun; 48(6):606-8. PubMed ID: 11273540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
    Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
    Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative bioavailability of two cefadroxil products using serum and urine data in healthy human volunteers.
    Otoom S; Hasan M; Najib N
    Clin Exp Pharmacol Physiol; 2004 Jul; 31(7):433-7. PubMed ID: 15236630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desorption of furosemide from charcoal in vitro and in man.
    Roivas L; Kivistö KT; Neuvonen PJ
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):365-9. PubMed ID: 7952799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variable furosemide absorption and poor predictability of response in elderly patients.
    Murray MD; Haag KM; Black PK; Hall SD; Brater DC
    Pharmacotherapy; 1997; 17(1):98-106. PubMed ID: 9017769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bioavailability and pharmacokinetics of a new nifedipine preparation in healthy volunteers].
    Hutt V; Molz KH; Pabst G; Dilger C; Mosberg H; Jaeger H
    Arzneimittelforschung; 1989 May; 39(5):607-11. PubMed ID: 2757680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers.
    Lesne M
    Arzneimittelforschung; 1988 Jan; 38(1A):160-3. PubMed ID: 3370062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bioequivalence of an optimized doxycycline preparation].
    Lode H; Deppermann N; Schmidt U
    Arzneimittelforschung; 1989 Sep; 39(9):1162-5. PubMed ID: 2590269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioequivalence of quinidine in two sustained-release preparations.
    Garty M; Rachmel A; Ilfeld D; Sinai Y; Paz R
    Isr J Med Sci; 1992 Jun; 28(6):357-61. PubMed ID: 1607272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetics and bioavailability of diphenhydramine in man].
    Gielsdorf W; Pabst G; Lutz D; Graf F
    Arzneimittelforschung; 1986 Apr; 36(4):752-6. PubMed ID: 3718600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation and in vitro examination of furosemide containing suppositories and preliminary experiences of their clinical use.
    Regdon G; Fazekas T; Regdon G; Selmeczi B
    Pharmazie; 1996 Feb; 51(2):116-9. PubMed ID: 8720807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
    Vargo DL; Kramer WG; Black PK; Smith WB; Serpas T; Brater DC
    Clin Pharmacol Ther; 1995 Jun; 57(6):601-9. PubMed ID: 7781259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of biological equivalence of two atenolol preparations.
    Wolf-Coporda A; Plavsić F; Vrhovac B
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):567-71. PubMed ID: 3323073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged-release hydroxypropyl methylcellulose matrix tablets of furosemide for administration to dogs.
    Smal J; Marvola M; Liljequist C; Happonen I
    J Vet Pharmacol Ther; 1996 Dec; 19(6):482-7. PubMed ID: 8971678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination and pharmacokinetics of a furosemide-amiloride drug combination.
    Jankowski A; Skorek-Jankowska A; Lamparczyk H
    J Chromatogr B Biomed Sci Appl; 1997 Jun; 693(2):383-91. PubMed ID: 9210443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.